The first publication of clinical results from
Gulsah Yildirim and Hakki Muammer Karakas, at Istanbul Fatih Sultan Mehmet Training and Research Hospital in Turkey, was published in May 2022.
They highlighted the
safety, feasibility, performance of this system. Following up the first 40 patients, without major complications. Antibody levels and thyroid function tests have remained within normal limits with no significant change during follow-ups. Symptoms and cosmetic scores were significantly improved at all follow-up.